Home > National Drug Code (NDC) > Pioglitazone

Pioglitazone - 0093-2046-56 - (pioglitazone)

Alphabetical Index


Drug Information of Pioglitazone

Product NDC: 0093-2046
Proprietary Name: Pioglitazone
Non Proprietary Name: pioglitazone
Active Ingredient(s): 45    mg/1 & nbsp;   pioglitazone
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Pioglitazone

Product NDC: 0093-2046
Labeler Name: Teva Pharmaceuticals USA Inc
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021073
Marketing Category: NDA AUTHORIZED GENERIC
Start Marketing Date: 20120817

Package Information of Pioglitazone

Package NDC: 0093-2046-56
Package Description: 30 TABLET in 1 BOTTLE (0093-2046-56)

NDC Information of Pioglitazone

NDC Code 0093-2046-56
Proprietary Name Pioglitazone
Package Description 30 TABLET in 1 BOTTLE (0093-2046-56)
Product NDC 0093-2046
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name pioglitazone
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20120817
Marketing Category Name NDA AUTHORIZED GENERIC
Labeler Name Teva Pharmaceuticals USA Inc
Substance Name PIOGLITAZONE HYDROCHLORIDE
Strength Number 45
Strength Unit mg/1
Pharmaceutical Classes Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient]

Complete Information of Pioglitazone


General Information